Premium
The Role of Candida Infections as an Adverse Effect upon Head and Neck Cancer Patients Undergoing Therapeutic Radiation and the Effect of Antimycotic Treatment
Author(s) -
Poland J.M.
Publication year - 1989
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/j.1439-0507.1989.tb02308.x
Subject(s) - adverse effect , medicine , head and neck cancer , head and neck , cancer , radiation therapy , oncology , surgery
Summary: Oral, pharyngeal and esoph‐ageal infections caused by Candida species occur very frequently when it comes to radiation therapy for head and neck cancer. In clinical terms oral candidosis is most often characterized by pseudomembranes or erythema. The erythematous form of oral candidosis has in particular to be distinguished from radiation mucositis. Candidosis of the oral and gastrointestinal tract often causes interruption of therapeutic radiation. Ketoconazole treatment is able to reduce the period of time during which the patient cannot be treated by radiation. Oral ketoconazole given at a daily dose of 200 mg is moreover superior to topical nystatin. To date, however, it is not yet clear if patients who have head and neck cancer in whom radiation therapy has to be started would profit from the prophylactic application of ketoconazole from start on.